financetom
Business
financetom
/
Business
/
Navigator Holdings Q1 Adjusted Earnings, Revenue Rise; Authorizes New Repurchase Program
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Navigator Holdings Q1 Adjusted Earnings, Revenue Rise; Authorizes New Repurchase Program
May 26, 2025 8:08 AM

04:54 PM EDT, 05/14/2025 (MT Newswires) -- Navigator Holdings ( NVGS ) reported Q1 adjusted earnings late Wednesday of $0.36 per diluted share, up from $0.32 a year earlier.

Three analysts surveyed by FactSet expected $0.32.

Revenue for the quarter ended March 31 was $151.4 million, up from $134.2 million a year earlier.

Analysts polled by FactSet expected $134.4 million.

The company said its board authorized the repurchase of $50 million of common shares.

The company kept its quarterly dividend at $0.05 per share, payable June 17 to holders of record May 29.

The company also said that the substantial doubt over its ability to continue as a going concern that was disclosed earlier has been alleviated.

Shares were up nearly 4% in after-hours trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--SL Green Realty Keeps Monthly Dividend at $0.25 a Share, Payable Dec. 16 to Shareholders of Record Nov. 29
--SL Green Realty Keeps Monthly Dividend at $0.25 a Share, Payable Dec. 16 to Shareholders of Record Nov. 29
Nov 19, 2024
10:08 AM EST, 11/18/2024 (MT Newswires) -- Price: 75.46, Change: -0.18, Percent Change: -0.24 ...
Contineum Says US FDA Clears IND Application for PIPE-791 to Treat Chronic Pain Linked to Osteoarthritis, Low Back Pain
Contineum Says US FDA Clears IND Application for PIPE-791 to Treat Chronic Pain Linked to Osteoarthritis, Low Back Pain
Nov 19, 2024
10:06 AM EST, 11/18/2024 (MT Newswires) -- Contineum Therapeutics ( CTNM ) said Monday the US Food and Drug Administration approved its investigational new drug application for PIPE-791 to treat chronic pain related to osteoarthritis and low back pain. The phase 1b trial to potentially treat the two indications is expected to start in Q1 2025, the company said, adding...
Safe Bulkers Approves 5 Million Share Buyback Program
Safe Bulkers Approves 5 Million Share Buyback Program
Nov 19, 2024
10:09 AM EST, 11/18/2024 (MT Newswires) -- Safe Bulkers ( SB ) said Monday it has approved a stock repurchase program to buyback 5 million of its shares. The company said it to plans to fund the repurchase program with its existing cash resources. Price: 4.34, Change: +0.07, Percent Change: +1.52 ...
MakeMyTrip Agrees To Acquire Happay, Bolstering Its Arsenal For Corporate Travel Solutions
MakeMyTrip Agrees To Acquire Happay, Bolstering Its Arsenal For Corporate Travel Solutions
Nov 19, 2024
MakeMyTrip Limited ( MMYT ) shares are trading higher premarket on Monday after the company inked a Business Transfer Agreement to acquire the Happay Expense Management Platform from CRED for an undisclosed amount. This acquisition strengthens MakeMyTrip’s position as a comprehensive solution provider for corporate travel and expense management. The transaction is expected to close within 90 days, pending closing...
Copyright 2023-2026 - www.financetom.com All Rights Reserved